[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-294403-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-294403-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","agenda-item-xi-executive-officers-report","Agenda Item XI - Executive Officer’s Report","","Executive Officer’s Report to the Board Members covering Agenda Item XI focuses on the Board’s response to the COVID-19 public health crisis. It describes communication reliance on the subscriber alert system, Twitter, and an updated website page that centralizes COVID-19 information. The report summarizes current and extended DCA Director waivers, including staffing ratio changes, vaccination-related flexibilities, mobile pharmacy licensing for testing, and multiple broad waivers with effective and expiration dates, plus details on waivers related to remote processing and duty to consult.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/healthcare/","Healthcare",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/agenda-item-xi-executive-officers-report/294403/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/agenda-item-xi-executive-officers-report/294403.png","ImageObject",300,407,{"name":42,"@type":43},"Đào","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-21","2026-09-17",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",11,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What communication tools does the Board use for COVID-19 related information?","Question",{"text":63,"@type":64},"The Board relies on its subscriber alert system, Twitter account, and website as primary communication tools for licensees and the public.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What staffing ratio change does the DCA waiver issued April 20, 2021 allow?",{"text":68,"@type":64},"It allows pharmacists exclusively initiating and administering COVID-19 vaccines, and pharmacy technicians exclusively administering vaccines under direct supervision, to increase the ratio to one pharmacist supervising no more than two pharmacy technicians.",{"name":70,"@type":61,"acceptedAnswer":71},"How many mobile pharmacies has the Board approved for COVID-19 testing?",{"text":72,"@type":64},"The Board has approved 55 mobile pharmacies for COVID-19 testing under the mobile pharmacy licensing process described in the report.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},294403,1790025609,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":108,"slug":109},7,40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":112,"show_sort_weight":113,"slug":114},8,"Research & Report",30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":107,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146},1374402968488,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","To: Board Members  \nSubject: Agenda Item XI. Executive Officer’s Report  \na. Discussion of Board’s Response to COVID-19 Pandemic and Actions Taken by Other Agencies  \nAs the pandemic has continued, the Board continues to dedicate significant resources to its response to the COVID-19 public health crisis both independently as well as in collaboration with other government agencies. The Board continues to rely on its subscriber alert system, Twitter account and website to serve as the primary communication tools for licensees and members of the public.  \nThe Board’s website was recently updated to centralize COVID related information on a dedicated webpage that is accessed from the Board’s homepage. This allows for stakeholders to find the information easily, while also ensuring stakeholders can easily find other important including alerts about changes in the law and recent information.  \nThe COVID-19 Information page includes a list of all current and expired Pharmacy Law waivers, with the text of the waivers available through a link and important information from the California COVID-19 Vaccination Program about vaccine coadministration, information on monoclonal antibody treatment, and waivers issued by the DCA Director.  \nDCA Director Waivers  \nOn April 20, 2021, DCA Director Kirchmeyer issued DCA Waiver DCA- 21-142 Order Waiving Staffing Ratio of Pharmacists to Pharmacy Technicians Relating to Administering COVID-19 Vaccines. Under the provisions of this waiver, pharmacists engaged exclusively in initiating and administering COVID-19 vaccines, and pharmacy technicians engaged exclusively in administering COVID-19 vaccines under the direct supervision and control of such pharmacist, may increase the ratio to allow one pharmacist to supervise no more than two pharmacy technicians.  \nSubsequent to the release of the DCA waiver, though his delegated authority, on April 21, 2021, President Lippe amended and reissued the Board’s Mass Vaccination Waiver to provide for a similar ratio increase, where the pharmacist and pharmacy technicians are solely involved in vaccinations, as specified. This waiver was subsequently extended by President Oh. Consistent with recent delegated authority, the waiver was again extended and will expire March 31, 2022, unless otherwise extended.  \nSeveral other DCA waivers remain in effect. On August 25, 2020, the DCA Director issued DCA-20-45, an order that waives specified professional licensing requirements and amends the scopes of practice of pharmacists and pharmacy technicians to allow them to perform waived, point-of-care tests used to detect SARS-CoV-2; this order remains in effect. As previously reported, the Board developed a process to issue mobile pharmacy licenses under the provisions of Business and Professions Code ( BPC) 4062 to pharmacies wishing to provide testing at temporary locations consistent with authorizing provisions found within the purview of Laboratory Field Services with the California Department of Public Health. To date the Board has approved 55 mobile pharmacies for this purpose of COVID-19 testing. The Board anticipates additional requests will be received as pharmacies receive approval from Laboratory Field Services.  \nFurther, on December 22, 2020, the DCA Director issued DCA-20-103, an order that waived provisions that prohibit pharmacy technicians from administering COVID-19 vaccines under specified conditions. Further, consistent with the mobile pharmacy licenses under the provisions of BPC 4062, a process was established for pharmacies wishing to use pharmacy technicians as part of the vaccination team outside of the license pharmacy. To date the Board has approved over 3,283 mobile pharmacies for this purpose.  \nBroad Waivers Issued/Extended  \nThe Board currently has 9 broad waivers. Provided below is a brief summary of each waiver and the current expiration date.  \n1.  Mass Vaccination Sites  \nSummary: Provides for the storage and redistribution of COVID-19 vac","cbCairxFWuOfb3G3","https://ap.wps.com/l/cbCairxFWuOfb3G3","pdf",996380,23,"English","# Agenda Item XI. Executive Officer’s Report\n## Board response to COVID-19 and communication tools\n## COVID-19 Information page and pharmacy law waivers\n## DCA Director Waivers\n## Broad Waivers Issued/Extended","[{\"question\":\"What communication tools does the Board use for COVID-19 related information?\",\"answer\":\"The Board relies on its subscriber alert system, Twitter account, and website as primary communication tools for licensees and the public.\"},{\"question\":\"What staffing ratio change does the DCA waiver issued April 20, 2021 allow?\",\"answer\":\"It allows pharmacists exclusively initiating and administering COVID-19 vaccines, and pharmacy technicians exclusively administering vaccines under direct supervision, to increase the ratio to one pharmacist supervising no more than two pharmacy technicians.\"},{\"question\":\"How many mobile pharmacies has the Board approved for COVID-19 testing?\",\"answer\":\"The Board has approved 55 mobile pharmacies for COVID-19 testing under the mobile pharmacy licensing process described in the report.\"}]","Agenda Item XI - Executive Officer’s Report | PDF",1789685143,58]